DMT
‘Blazing Saddles’ screenwriter Norman Steinberg dead at 83
Norman Steinberg, the co-writer of the Mel Brooks-fronted comedy “Blazing Saddles” and an Emmy winner for Flip Wilson’s 1970s variety show, has…
Norman Steinberg, the co-writer of the Mel Brooks-fronted comedy “Blazing Saddles” and an Emmy winner for Flip Wilson’s 1970s variety show, has died. He was 83.
Deadline reported Wednesday that Steinberg’s family said he died March 15, but did not provide further details.
The Post has contacted a rep for Steinberg for comment.
“It’s a sad day when Norman Steinberg leaves us. From BLAZING SADDLES to MY FAVORITE YEAR, he was one of the best writers I ever worked with,” Brooks, 96, tweeted Wednesday.
“I’m so glad I rescued him from a dull stable legal career, because he always permeated the writers room with his infectious comic spirit,” he added.
Born in Brooklyn on June 6, 1939, Steinberg was working as a lawyer when he met Brooks in the 1960s at a Manhattan coffee shop, Deadline reported.
Brooks convinced him to quit his day job, and he moved to LA to write.
Steinberg was one of the writers to win an Emmy in 1971 for NBC’s comedy-variety series “The Flip Wilson Show.”
Brooks hired him and dentist-turned-writer Alan Uger to pen the script for what would become “Blazing Saddles.”
The comedy was one of the hits of 1974, grossing $119.5 million at the domestic box office.
Steinberg’s other writing credits include “Yes, Giorgio” (1982), “My Favorite Year” (1982), the Michael Keaton comedy “Johnny Dangerously” (1984), “Wise Guys” (1986), and “Funny About Love” (1990).
He also worked on the TV projects “Cosby” and “Paradise” and created “Doctor Doctor,” a CBS sitcom that ran from 1989 to 1991.
He wrote and executive produced Bob Saget’s sitcom “Raising Dad,” which aired from 2001 to 2002.
Steinberg is survived by his wife, Serine Hastings, and his children, Nik and Daphne, whom he shares with his first wife, Bonnie Strock.
The post ‘Blazing Saddles’ screenwriter Norman Steinberg dead at 83 appeared first on REPORT DOOR.
dimitri-
Psychedelics1 week ago
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
-
Law & Regulation1 week ago
Going concern warnings cloud Xtacy Therapeutics’ shrunk losses
-
Psilocybin1 week ago
Are Shrooms Legal in Oregon: Full Guide
-
Law & Regulation1 week ago
Numinus reports declining revenue as the company restructures
-
Psychedelics1 week ago
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
-
Psychedelics1 week ago
Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
-
Psychedelics1 week ago
Atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
-
Law & Regulation7 days ago
Clearmind signs agreement with Hebrew University for psychedelic compound rights